Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

Published:2021-07 Issue:1 Volume:78 Page:14-23
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Eikelboom John W.,Bhatt Deepak L.,Fox Keith A.A.,Bosch Jacqueline,Connolly Stuart J.,Anand Sonia S.,Avezum Alvaro,Berkowitz Scott D.,Branch Kelley R.H.,Dagenais Gilles R.,Félix Camilo,Guzik Tomasz J.,Hart Robert G.,Maggioni Aldo P.,Muehlhofer Eva,Sharma Mukul,Shestakovska Olga,Yusuf Salim

Funder

Sanofi

AstraZeneca

Boehringer Ingelheim

Bayer

Janssen Pharmaceuticals

Eli Lilly and Company

Servier

Pfizer

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Rivaroxaban with or without aspirin in stable cardiovascular disease;Eikelboom;N Engl J Med,2017

2. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial;Connolly;Lancet,2018

3. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial;Anand;Lancet,2018

4. Rationale, design, and baseline characteristics of participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial;Bosch;Can J Cardiol,2017

5. Monitoring emerging data from the COMPASS trial of an antithrombotic agent;Cairns;J Am Coll Cardiol,2019

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Strategies for Patients With Peripheral Artery Disease;Journal of the American College of Cardiology;2024-09

2. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30

3. Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment;Current Cardiology Reports;2024-05-14

4. Mortality associated with peripheral artery disease of the legs;Vnitřní lékařství;2024-05-06

5. Occupational Risks of Radiation Exposure to Cardiologists;Current Cardiology Reports;2024-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3